Literature DB >> 1851554

Transcriptional interference between the EBV transcription factors EB1 and R: both DNA-binding and activation domains of EB1 are required.

J F Giot1, I Mikaelian, M Buisson, E Manet, I Joab, J C Nicolas, A Sergeant.   

Abstract

The switch from latency to a productive infection in EBV-infected B cells is linked to the expression of two viral sequence-specific DNA-binding transcription factors called EB1 and R. EB1 shares sequence homologies with the bZIP family of proteins in the basic region required for specific DNA interaction. Here, we provide evidence that EB1 and R can synergistically activate specific transcription, and that overexpressed, unbound EB1, represses the R-induced transcription ('squelching'). In order to identify the EB1 domains involved in transcriptional activation, transcriptional synergy and transcriptional repression, we performed extensive mutagenesis of the EB1 protein. Results show that five segments (region 1 to region 5), localized at the N-terminus of EB1 exhibit characteristics of activating domains, since they are required for full transcriptional activity, without obvious role in DNA-binding, or the nuclear localization. Two domains rich in basic amino-acids are required for the nuclear localization of EB1. One domain is within the basic region B, also necessary for specific and stable interaction between EB1 and its cognate DNA sequences. It is also shown that the 'activation' domain, and more surprisingly the DNA-binding domain of EB1, may interact with a factor(s), essential for R-induced activation, and probably required for synergy between EB1 and R.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1851554      PMCID: PMC333850          DOI: 10.1093/nar/19.6.1251

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  43 in total

1.  Evidence for coiled-coil dimer formation by an Epstein-Barr virus transactivator that lacks a heptad repeat of leucine residues.

Authors:  E Flemington; S H Speck
Journal:  Proc Natl Acad Sci U S A       Date:  1990-12       Impact factor: 11.205

2.  A novel mediator between activator proteins and the RNA polymerase II transcription apparatus.

Authors:  R J Kelleher; P M Flanagan; R D Kornberg
Journal:  Cell       Date:  1990-06-29       Impact factor: 41.582

3.  The Epstein-Barr virus BMLF1 promoter contains an enhancer element that is responsive to the BZLF1 and BRLF1 transactivators.

Authors:  S Kenney; E Holley-Guthrie; E C Mar; M Smith
Journal:  J Virol       Date:  1989-09       Impact factor: 5.103

4.  The Epstein-Barr virus (EBV) DR enhancer contains two functionally different domains: domain A is constitutive and cell specific, domain B is transactivated by the EBV early protein R.

Authors:  A Chevallier-Greco; H Gruffat; E Manet; A Calender; A Sergeant
Journal:  J Virol       Date:  1989-02       Impact factor: 5.103

5.  Cognate DNA binding specificity retained after leucine zipper exchange between GCN4 and C/EBP.

Authors:  P Agre; P F Johnson; S L McKnight
Journal:  Science       Date:  1989-11-17       Impact factor: 47.728

6.  Identification and characterization of oriLyt, a lytic origin of DNA replication of Epstein-Barr virus.

Authors:  W Hammerschmidt; B Sugden
Journal:  Cell       Date:  1988-11-04       Impact factor: 41.582

Review 7.  Latency comes of age for herpesviruses.

Authors:  V R Baichwal; B Sugden
Journal:  Cell       Date:  1988-03-25       Impact factor: 41.582

8.  Analysis of Sp1 in vivo reveals multiple transcriptional domains, including a novel glutamine-rich activation motif.

Authors:  A J Courey; R Tjian
Journal:  Cell       Date:  1988-12-02       Impact factor: 41.582

9.  A new Epstein-Barr virus transactivator, R, induces expression of a cytoplasmic early antigen.

Authors:  J M Hardwick; P M Lieberman; S D Hayward
Journal:  J Virol       Date:  1988-07       Impact factor: 5.103

10.  A detailed mutational analysis of Vmw110, a trans-acting transcriptional activator encoded by herpes simplex virus type 1.

Authors:  R D Everett
Journal:  EMBO J       Date:  1987-07       Impact factor: 11.598

View more
  40 in total

1.  Genetic dissection of cell growth arrest functions mediated by the Epstein-Barr virus lytic gene product, Zta.

Authors:  A Rodriguez; M Armstrong; D Dwyer; E Flemington
Journal:  J Virol       Date:  1999-11       Impact factor: 5.103

2.  A specific lysine in c-Jun is required for transcriptional repression by E1A and is acetylated by p300.

Authors:  R G Vries; M Prudenziati; C Zwartjes; M Verlaan; E Kalkhoven; A Zantema
Journal:  EMBO J       Date:  2001-11-01       Impact factor: 11.598

3.  Activation of the BRLF1 promoter and lytic cycle of Epstein-Barr virus by histone acetylation.

Authors:  L K Chang; S T Liu
Journal:  Nucleic Acids Res       Date:  2000-10-15       Impact factor: 16.971

4.  The Epstein-Barr virus immediate-early promoter BRLF1 can be activated by the cellular Sp1 transcription factor.

Authors:  S Zalani; E A Holley-Guthrie; D E Gutsch; S C Kenney
Journal:  J Virol       Date:  1992-12       Impact factor: 5.103

5.  Epstein-Barr virus BZLF1 protein binds to mitotic chromosomes.

Authors:  Amy L Adamson
Journal:  J Virol       Date:  2005-06       Impact factor: 5.103

6.  Characterization of the Epstein-Barr virus BZLF1 protein transactivation domain.

Authors:  E K Flemington; A M Borras; J P Lytle; S H Speck
Journal:  J Virol       Date:  1992-02       Impact factor: 5.103

7.  The cellular oncogene c-myb can interact synergistically with the Epstein-Barr virus BZLF1 transactivator in lymphoid cells.

Authors:  S C Kenney; E Holley-Guthrie; E B Quinlivan; D Gutsch; Q Zhang; T Bender; J F Giot; A Sergeant
Journal:  Mol Cell Biol       Date:  1992-01       Impact factor: 4.272

8.  Activation of the Epstein-Barr virus DNA polymerase promoter by the BRLF1 immediate-early protein is mediated through USF and E2F.

Authors:  C Liu; N D Sista; J S Pagano
Journal:  J Virol       Date:  1996-04       Impact factor: 5.103

9.  The Epstein-Barr virus bZIP transcription factor Zta causes G0/G1 cell cycle arrest through induction of cyclin-dependent kinase inhibitors.

Authors:  C Cayrol; E K Flemington
Journal:  EMBO J       Date:  1996-06-03       Impact factor: 11.598

10.  Modeling early Epstein-Barr virus infection in Drosophila melanogaster: the BZLF1 protein.

Authors:  Amy L Adamson; Natasha Wright; Dennis R LaJeunesse
Journal:  Genetics       Date:  2005-08-03       Impact factor: 4.562

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.